MARKET

BFRI

BFRI

Biofrontera Inc
NASDAQ
0.7787
-0.0113
-1.43%
After Hours: 0.7635 -0.0152 -1.95% 19:47 02/13 EST
OPEN
0.7821
PREV CLOSE
0.7900
HIGH
0.7904
LOW
0.7656
VOLUME
114.77K
TURNOVER
--
52 WEEK HIGH
1.190
52 WEEK LOW
0.5360
MARKET CAP
9.07M
P/E (TTM)
-0.4222
1D
5D
1M
3M
1Y
5Y
1D
Biofrontera's Ameluz SNDA For Superficial Basal Cell Carcinoma Accepted By FDA
NASDAQ · 2d ago
Biofrontera announces FDA acceptance of sNDA for Ameluz PDT
TipRanks · 2d ago
Biofrontera's Supplemental New Drug Application For Ameluz Accepted By FDA
Benzinga · 2d ago
FDA Accepts Biofrontera sNDA Filing for Ameluz PDT in Superficial Basal Cell Carcinoma
Reuters · 2d ago
BIOFRONTERA INC - FDA SETS PDUFA DATE FOR SEPTEMBER 28, 2026
Reuters · 2d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 4d ago
Biofrontera Reports Positive Phase 3 Ameluz PDT Results
TipRanks · 4d ago
Biofrontera announces positive Phase 3 results for Ameluz PDT
TipRanks · 4d ago
More
About BFRI
Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Webull offers Biofrontera Inc stock information, including NASDAQ: BFRI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRI stock methods without spending real money on the virtual paper trading platform.